Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | RVG29-LNP@PTX, RVG29-modified paclitaxel-loaded lipid nanoparticles |
| Catalog Number | R-ZHIGF14 |
| Alias | RVG29-modified paclitaxel-loaded lipid nanoparticles |
| Appearance | Dispersion |
| Molecular Formula | N/A |
| Solubility | Dispersed in water and some organic solvents |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | Targeted drug delivery |
| Specification | 100mg:Inquiry 500mg:Inquiry 1g: Inquiry |
| Description | RVG29-LNP@PTX is a targeted drug delivery system. Among them, RVG29 is a 29-amino acid bioactive peptide derived from the harmful glycoprotein of rabies. It can specifically recognize and bind to the α-7 subunit of the nicotinic acetylcholine receptor (nAChR) on neuronal cells. This property enables vectors modified with RVG29 to have the ability to target delivery to the nervous system. |